Skip to main content
ARS Home » Northeast Area » Boston, Massachusetts » Jean Mayer Human Nutrition Research Center On Aging » Research » Publications at this Location » Publication #360126
Title: Nutritional intervention in sarcopenia: report from the International Conference on Frailty and Sarcopenia Research Task Force

Author
item LANDI, FRANCESCO - Catholic University Of The Sacred Heart Italy
item SIEBER, CORNEL - Friedrich-Alexander University
item FIELDING, ROGER - Jean Mayer Human Nutrition Research Center On Aging At Tufts University
item ROLLAND, YVES - La Grave Hospital
item GURALNIK, JACK - University Of Maryland

Submitted to: The Journal of Frailty and Aging
Publication Type: Review Article
Publication Acceptance Date: 5/17/2018
Publication Date: 9/20/2018
Citation: Landi, F., Sieber, C., Fielding, R.A., Rolland, Y., Guralnik, J. 2018. Nutritional intervention in sarcopenia: report from the International Conference on Frailty and Sarcopenia Research Task Force. The Journal of Frailty and Aging. 7(4):247-252. https://doi.org/10.14283/jfa.2017.26.
DOI: https://doi.org/10.14283/jfa.2017.26

Interpretive Summary:

Technical Abstract: Research suggests that poor nutrition is an underlying cause of sarcopenia and frailty, and that dietary interventions may prevent or treat age-related loss of muscle mass and strength. In February 2018, the International Conference on Frailty and Sarcopenia Research Task Force explored the current status of research on nutritional interventions for sarcopenia as well as gaps in knowledge, including whether nutritional supplements must be combined with physical activity, and the role of nutritional intervention in sarcopenic obese individuals. The lack of consistency across trials in terms of target populations, assessments, health-care settings, control groups, and choice of outcomes has made it difficult to draw meaningful conclusions from recent studies. The Task Force recommended large randomized controlled trials in heterogeneous, real-world populations to enable sub-group analysis. The field also needs to reach consensus on what outcomes are most meaningful and what represents clinically meaningful change.